The new sarcoma research team
Cancer Centre
Team
Sarcoma Translational Research projects
Reports and Findings
Improving compliance with swallowing exercise to decrease radiotherapy-related dysphagia in patients with head and neck cancer
Dysphagia, one of the most common complications in head and neck cancer (HNC) treated with radiotherapy, can severely affect patients’ quality of life. Currently, because no “gold standard” treatment exists, swallowing exercise remains the main rehabilitation strategy for dysphagia. However, patients’ compliance with long-term swallowing exercise is only 40%, thus, greatly compromising outcomes. This article aims to analyze thefactors influencing swallowing exercise compliance in patients with HNC and explains strategies developed to date for improved rehabilitation outcomes.
Children's Cancers Published research Sarcoma Translational ResearchCD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy
While chemotherapy remains the first-line treatment for many cancers, it is still unclear what distinguishes responders from non-responders. Here, we characterize the chemotherapy-responsive tumor microenvironment in mice, using RNA sequencing on tumors before and after cyclophosphamide, and compare the gene expression profiles of responders with progressors.
Children's Cancers Published research Computational Biology Sarcoma Translational Research Translational GeneticsGenes involved in platelet aggregation and activation are downregulated during acute anaphylaxis in humans
Mechanisms underlying the anaphylactic reaction in humans are not fully understood. Here, we aimed at improving our understanding of anaphylaxis by investigating gene expression changes.
Published research Sarcoma Translational ResearchAnoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
Glioblastoma is the most common form of high-grade glioma in adults and has a poor survival rate with very limited treatment options. There have been no significant advancements in glioblastoma treatment in over 30 years. Epidermal growth factor receptor is upregulated in most glioblastoma tumours and, therefore, has been a drug target in recent targeted therapy clinical trials.
Children's Cancers Published research Brain Tumour Research Oncogenic Signalling Laboratory Sarcoma Translational Research